Artículos de revistas
Cognitive impairment in antiphospholipid syndrome: evidence from animal models
Registro en:
Clinical Rheumatology. Springer, v.31, n.3, p.403-406, 2012
0770-3198
WOS:000303448900001
10.1007/s10067-011-1922-z
Autor
Appenzeller, Simone
Lapa, Aline Tamires
Guirau, Caio Rodrigues
de Carvalho, Jozelio Freire
Shoenfeld, Yehuda
Institución
Resumen
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Although antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, its inflammatory nature has been increasingly recognized in recent years. Stroke and transitory ischemic attacks are the neurological manifestations included in APS criteria, however many other neurological involvements have been attributed to antiphospholipid antibodies (aPL), such as seizures, transverse myelitis, and cognitive impairment. In this article we will review evidence from animal model that explain the role of aPL in cognition. 31 3 403 406 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Federico Foundation Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)